Search
Cibus Inc
CBUSAdd to Watchlist
1.715USD
-0.065-3.65%
Market hours （ET）Quotes delayed by 15 min
130.83MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Cibus Inc is 7.33, ranking 144 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 15.50, with a high of 25.00 and a low of 1.60.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
14.667
Target Price
+688.53%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Cibus Inc
CBUS
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cibus Inc's expected revenue for the next quarter?
Cibus Inc's expected revenue is 1.70M.
What is Cibus Inc's price target?
Analysts forecast that Cibus Inc's price target is USD 15.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 1.60.
How have Cibus IncCBUS's recent earnings per share performed?
The market expectation was USD -0.33, while Cibus IncCBUS's earnings per share (EPS) for the previous quarter was USD -0.59. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for Cibus Inc?
Based on the ratings of Cibus Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.